
|Articles|October 23, 2007
FDA extends deadline for e-prescribing comments
Dec. 6 is new deadline for public comments regarding electronic distribution of prescribing information for Rx drugs.
Advertisement
Apparently not satisfied with the volume of comments it has received, the FDA has extended the comment period regarding electronic distribution of prescribing information for prescription drug products. The new deadline for comments, as published in the Oct. 22
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: Fentanyl, Opiophobia Concurrently Contribute to Ongoing Opioid Crisis
2
Finerenone Shows Benefits for Chronic Kidney Disease for Patients With Type 1 Diabetes
3
Expansion of OTC Contraceptive Could Fill Reproductive Health Disparities
4
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
5




















































































































































